Alpha Tau reports 100% response rate in head and neck cancer combo trial Jul 21, 2026 08:32AM
Alpha Tau reports interim brain cancer trial results in 3 patients May 11, 2026 07:01AM
Alpha Tau to present head and neck cancer study at AHNS conference May 5, 2026 09:15AM
Alpha Tau reports 100% disease control in pancreatic cancer trials May 4, 2026 09:17AM
Alpha Tau abstract accepted at ASCO annual meeting for pancreatic cancer data Apr 27, 2026 09:01AM


May 12, 2025 04:01PM Alpha Tau Medical (DRTS) Appoints Nadav Kidron to its Board
Oct 21, 2024 08:32AM Alpha Tau Medical (DRTS) Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme